Translational highlights in breast cancer research and treatment: recent developments with clinical impact

Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm

Saved in:
Bibliographic Details
Main Authors: Fasching, Peter Andreas (Author) , Schneeweiss, Andreas (Author) , Kolberg, Hans-Christian (Author) , Ettl, Johannes (Author) , Fehm, Tanja (Author) , Overkamp, Friedrich (Author) , Lüftner, Diana (Author)
Format: Article (Journal)
Language:English
Published: 2019/02/01
In: Current opinion in obstetrics and gynecology
Year: 2019, Volume: 31, Issue: 1, Pages: 67-75
ISSN:1473-656X
DOI:10.1097/GCO.0000000000000510
Online Access:Verlag, Volltext: https://doi.org/10.1097/GCO.0000000000000510
Get full text
Author Notes:Peter A. Fasching, Andreas Schneeweiss, Hans-Christian Kolberg, Johannes Ettl, Tanja Fehm, Friedrich Overkamp, and Diana Lüftner
Description
Summary:Purpose of reviewOver the last decades the time which is needed to translate a preclinical finding or idea in the clinic has reduced continuously. Especially but not only for breast cancer the number of tested drugs and targeted pathways have increased immensely. In addition, the introduction of imm
Item Description:Gesehen am 10.07.2019
Physical Description:Online Resource
ISSN:1473-656X
DOI:10.1097/GCO.0000000000000510